Yuanxiang Wang1, Brendan Frett, Hong-yu Li. 1. Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona , Tucson, Arizona 85721, United States.
Abstract
An expeditious one-pot, ligand-free, Pd(OAc)2-catalyzed, three-component reaction for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines was developed under microwave irradiation. With the high availability of commercial reagents and great efficiency in expanding molecule diversity, this methodology is superior to the existing procedures for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines analogues.
An expeditious one-pot, ligand-free, Pd(OAc)2-catalyzed, three-component reaction for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines was developed under microwave irradiation. With the high availability of commercial reagents and great efficiency in expanding molecule diversity, this methodology is superior to the existing procedures for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines analogues.
Imidazo[1,2-a]pyridines
are extremely popular among chemists and medicinal chemists
due to their remarkable biological and pharmacological activities[1] such as anticancer,[2] anti-inflammatory,[3] antibacterial,[4] antiprotozonal,[5] antiviral,[6] antiulcer,[7] and antifungal.[8] Within the imidazo[1,2-a]pyridine
family, several products have progressed to market, including alpidem
(anxiolytic),[9] necopidem (anxiolytic),[10] saripidem (anxiolytic),[11] zolpidem (insomnia),[12] olprinone (cardiotonic),[13] minodronic acid (bisphosphonate),[14] divalpon (anxiolytic),[15] and zolimidine (antiulcer).[16]The
imidazo[1,2-a]pyridine derivatives, 2,3-diarylimidazo[1,2-a]pyridines also exhibit a wide range of biological activities.[17] In particular, medicinal chemists have focused
on the core structure to produce inhibitors[18] for PI3K, p38, and TGF-β kinases. Owing to the attractive
biological properties of 2,3-diarylimidazo[1,2-a]pyridines,
a variety of strategies to synthesize the core structure have been
developed, focusing on (1) condensation between 2-aminopyridines and
2-bromo-1,2-diarylethanone;[19] (2) Suzuki-type
cross-coupling between 3-halo-2-arylimidazo[1,2-a]pyridines and arylboronic acid,[20] and
(3) copper-catalyzed conversion of pyridine to 2,3-diarylimidazo[1,2-a]pyridines.[21] Very recently,
Pd-, Rh-, and Cu- catalyzed direct C–H arylations of 2-arylimidazo[1,2-a]pyridines at C-3 have been extensively studied (Scheme 1a).[22] The transformation
is completed in stepwise sequences to afford 2,3-diarylimidazo[1,2-a]pyridines. Therefore, an efficient synthetic methodology
involving commercially available and inexpensive starting materials
is required to expeditiously synthesize diverse 2,3-diarylimidazo[1,2-a]pyridines. In order to develop a convenient synthetic
route in conjunction with the possibility for rapid library diversification,
we were interested in conducting the two-step cyclization/C–H
arylation in one pot (Scheme 1b). To the best
of our knowledge, there has never been a report of a one-pot, ligand-free,
palladium-catalyzed, three-component reaction to afford 2,3-diarylimidazo[1,2-a]pyridines under microwave irradiation.
Scheme 1
Methods for the Synthesis of 2,3-Diarylimidazo[1,2-a]pyridines
2-Aminopyridine (1a), 2-bromo-1-phenylethanone
(2a), and 1-bromo-4-nitrobenzene (3a) were
chosen
as model substrates to optimize the reaction conditions. We initiated
our studies by examining the influence of microwave irradiation on
the conversion using KOAc as the base and 10 mol % of Pd(OAc)2 as the catalyst. First, we carried out a reaction in DMF
at 100 °C under microwave irradiation for 30 min, but only trace
amounts of product 4aaa were detected (19% yield, Table 1, entry 1). Increasing the temperature from 100
to 120 °C improved the yield to 36% (entry 2). A high yield of
66% was obtained with a temperature of 160 °C (entry 4). Unfortunately,
yields decreased with higher temperatures (entries 5 and 6). The yield
was optimized to 84% by increasing the reaction time to 1 h (entry
7). Then, the reaction was performed using different catalyst loads
(entry 8–11). In the presence of 8 mol % of Pd(OAc)2, a yield of 78% was obtained and a significant yield was lost with
lower catalytic loads.
Reaction conditions: 1a (1 mmol), 2a (1
mmol), 3a (2 mmol), base
(2 mmol), solvent (6 mL).Isolated yield.A variety
of bases were investigated, such as KOAc, CsOAc, NaOAc,
K2CO3, and Cs2CO3. KOAc
was identified as the best base (Table 1).
Finally, our study focused on testing various solvents, such as DMF,
DMAc, NMP, xylene, dioxane, and 1-butanol, and among them, DMF was
found to be superior (Table 1).
Scope of
Phenyl Bromides,
Reaction conditions: 1a (1 mmol), 2a (1
mmol), 3 (2 mmol), Pd(OAc)2 (10 mol %), KOAc
(2 mmol), DMF (6 mL), microwave, 160 °C,
1 h.Isolated yield.Reaction time is 2 h.With the optimized reaction conditions in hand, we
evaluated the
scope and limitations of the transformation. We initially assessed
the reactions of various aryl bromides with 1a and 2a (Scheme 2). First, a series of para- or meta-substituted electron-deficient
aryl bromides were examined under the optimized conditions, and the
corresponding products (4aaa–d) were
produced in good to excellent yields. Subsequently, disubstituted
aryl bromides were subjected to the reaction and transformation occurred
smoothly. The one-pot three component reaction also worked well with
bromopyridine or bromopyrimidine, leading to the products (4aag–i) in good yields. Bromobenzene was also successfully
employed in the reaction to produce 4aaj in 72% yield.
It should be noted that electron-rich aryl bromides gave slightly
lower yields than electron-deficient systems, affording the corresponding 4aak–m in 56–60% yields. Biphenyl
bromide and 4-bromoisoquinoline were also found to be suitable partners,
giving 4aan and 4aao in yields of 66% and
68%, respectively.
Scope of Aminopyridines and 2-Bromophenylethanones,
Reaction
conditions: 1a (1 mmol), 2a (1 mmol), 3 (2 mmol), Pd(OAc)2 (10 mol %), KOAc (2 mmol),
DMF (6 mL), microwave, 160 °C,
1 h;Isolated yield.To further examine the efficiency of this one-pot
reaction and
to rapidly expand our unique compound collection, we extended the
reaction scope to other 2-aminopyridines and 2-(bromophenyl)ethanones.
As shown in Scheme 3, we were pleased to find
that methyl substituted 2-aminopyridines could be smoothly transformed
into the desired products (4baa and 4caa in 83% and 78% yield, respectively). The electron-withdrawing (−CN)
substituent was well tolerated (4daa). To our delight,
when 2-bromo-1-(4-fluorophenyl)ethanone, 4-(bromoacetyl)pyridine,
and 2-(bromoacetyl)pyridine were subjected to the reaction, the corresponding
products (4bba–bda) could be isolated
in good to excellent yields (Scheme 3).
Scheme 3
Scope of Aminopyridines and 2-Bromophenylethanones,
The reaction is not limited to synthesis of 2,3-diarylimidazo[1,2-a]pyridines. Under the same reaction conditions, 2-chloroacetaldehyde
was successfully coupled with 1a and 3a to
afford 2-arylimidazo[1,2-a]pyridine 6 in 65% yield (Scheme 4).
Scheme 4
Synthesis of 3-(4-Nitrophenyl)imidazo[1,2-a]pyridine
via the One-Pot Procedure
We also prepared
compounds 4bca and 4bdh in yields of 77%
and 75%, which have been found to be active on
the TGFβ-R1 kinase through a high-throughput computational screen
(Figure 1).[23] Interestingly,
both compounds are predicted to bind the kinase in a similar fashion
to known TGFβ-R1 inhibitors (Figure 1)[24] and have calculated properties with
druglike space (Table 2).
Figure 1
Computational modeling of 4bca (A) and 4bdh (B) in the TGFβ-R1 kinase (PDB: 3FAA(24)). In both
cases, a pyridine moiety hydrogen bonds to the hinge with H283. 4bca creates a contact with the conserved lysine, L232. Both
compounds access a lipophilic pocket to the left of L232. The hinge
is shown in green, the DFG motif is shown in purple, and the C-Helix
is shown in orange. Ligand/receptor interactions are denoted with
black dotted lines.
Table 2
TGFβ-R1
Computational Affinity
and Drug Properties
compd
ΔGa (kcal/mol)
Kdb (nM)
CLogPc
tPSAc (Å2)
MW (g/mol)
4bca
–10.4
23.3
3.8
79.8
330
4bdh
–9.2
177.3
2.8
40.3
286
Calculated with Autodock Vina.
Calculated from ΔG using Kd = e–Δ at 298 K.
Calculated with ChemDraw.
Computational modeling of 4bca (A) and 4bdh (B) in the TGFβ-R1 kinase (PDB: 3FAA(24)). In both
cases, a pyridine moiety hydrogen bonds to the hinge with H283. 4bca creates a contact with the conserved lysine, L232. Both
compounds access a lipophilic pocket to the left of L232. The hinge
is shown in green, the DFG motif is shown in purple, and the C-Helix
is shown in orange. Ligand/receptor interactions are denoted with
black dotted lines.Calculated with Autodock Vina.Calculated from ΔG using Kd = e–Δ at 298 K.Calculated with ChemDraw.In summary, we have developed an expeditious one-pot
procedure
to access 2,3-diarylimidazo[1,2-a]pyridines via a
ligand-free, palladium-catalyzed, microwave-assisted three-component
reaction. In addition, the availability of reagents and ease in expanding
molecule diversity make the developed methodology operationally proficient
and can facilitate rapid library construction. Further efforts to
therapeutically evaluate the synthesized compounds are underway and
will be reported in due course.
Authors: Robert R Singhaus; Ronald C Bernotas; Robert Steffan; Edward Matelan; Elaine Quinet; Ponnal Nambi; Irene Feingold; Christine Huselton; Anna Wilhelmsson; Annika Goos-Nilsson; Jay Wrobel Journal: Bioorg Med Chem Lett Date: 2009-11-23 Impact factor: 2.823
Authors: Mohamed A Ismail; Reem K Arafa; Tanja Wenzler; Reto Brun; Farial A Tanious; W David Wilson; David W Boykin Journal: Bioorg Med Chem Date: 2007-10-18 Impact factor: 3.641
Authors: Steven L Colletti; Jessica L Frie; Elizabeth C Dixon; Suresh B Singh; Bernard K Choi; Giovanna Scapin; Catherine E Fitzgerald; Sanjeev Kumar; Elizabeth A Nichols; Stephen J O'Keefe; Edward A O'Neill; Gene Porter; Koppara Samuel; Dennis M Schmatz; Cheryl D Schwartz; Wesley L Shoop; Chris M Thompson; James E Thompson; Ruixiu Wang; Andrea Woods; Dennis M Zaller; James B Doherty Journal: J Med Chem Date: 2003-01-30 Impact factor: 7.446
Authors: Brendan Frett; Nick McConnell; Catherine C Smith; Yuanxiang Wang; Neil P Shah; Hong-yu Li Journal: Eur J Med Chem Date: 2015-02-28 Impact factor: 6.514